YA II PN, Ltd. 13D and 13G filings for Kiromic BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-20 12:06 pm Purchase | 2022-10-13 | 13G | Kiromic BioPharma, Inc. KRBP | YA II PN, Ltd. | 56,366 9.990% | 56,366 (New Position) | Filing |